RBR-5qyszr9尚未招募未知
Assessment of primary dermal irritability, accumulated dermal irritability, and dermal sensitization (HRIPT)
Medicin Instituto da Pele Ltda0 个研究点开始时间: 2022年7月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 70Y（—）
入选标准
- •Participants of both sexes; age between 18 and 70 years; phototypes: I, II, III and IV (according to the Fitzpatrick adapted scale – Annex 1); intact test region skin; agreement to comply with the trial procedures and to attend the clinic on the days and times determined for the medical evaluations and for the application and reading of the dressings, understanding, consent and signing the Free and Informed Consent Form (FICT)
排除标准
- •Participants who have been diagnosed with COVID-19 in the last 4 weeks or who have symptoms such as fever, dry cough, tiredness, body aches or other discomforts; pregnancy or risk of pregnancy and/or lactation (when female); use of anti-inflammatory drugs for 30 days and/or immunosuppressants for up to three months before selection; immunosuppression by drugs or active diseases, decompensated endocrinopathies; personal history of atopy; intense sun exposure or tanning sessions up to 15 days before the assessment or during the study period; predicted intense exposure to sunlight or tanning sessions during the study period; forecast of bathing in the sea, swimming pool or sauna during the study; practice of water sports during the study; dermographism; use of oral or topical treatment with vitamin A acid and/or its derivatives up to 1 month before the start of the study; cosmetic and/or dermatological treatment on the body within 3 weeks prior to selection; scheduled vaccination during the study period or up to 3 weeks before selection; history of sensitization and irritation to topical product; active skin pathologies (local and/or disseminated) that could interfere with the study results; use of new drugs and/or cosmetics during the study; skin reactivity; previous participation in studies with the same product; congenital or acquired immunodeficiency; relevant medical history or current evidence of alcohol or other drug abuse; known or suspected history of intolerance to any ingredient in study products (test or comparative products); history of non-adherence or unwillingness to adhere to the study protocol; employees of Medcin or the sponsoring company involved in the study, or a close family member of an employee involved in the study, or other conditions deemed by the researcher to be reasonable for disqualification from participation in the study
研究者
相似试验
尚未招募
Unknown
Assessment of skin irritability after using a health product responsible for reinforcing the skin's protection barrier, preventing microorganisms that cause skin diseasesAccidental InjuryNon-penetrating WoundsPenetrating WoundsDermatopathiesRBR-7jc7btrMedicin Instituto da Pele Ltda
尚未招募
不适用
Evaluation of irritability and sensitization of health products, through the contact test.RBR-3k6982Makelab Consultoria Eireli
尚未招募
不适用
Evaluation of irritability and sensitization of cream for Psoriasis through the Contact TestPsoriasisRBR-2j4j5grTCI BIOTECNOLOGIA LTDA
招募中
1 期
Assessment of immediate and prolonged skin irritation and / or allergy.Healthy VolunteersM01.774.500RBR-72tgnyMedcin Instituto da Pele Ltda.
已完成
不适用
Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Photosensitization of a Scar GelSensitivity, ContactPhotosensitivityPhototoxicityNCT06723340Herbarium Laboratorio Botanico Ltda55